Phase II Study of Everolimus Combined With Octreotide LAR to Treat Advanced GI NET
Clinical trial NCT01567488 · COMPLETED
Trial details
- NCT number
- NCT01567488
- Sponsor
- Grupo Espanol de Tumores Neuroendocrinos
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2011-06-08
- Primary completion
- 2014-09-01
- Enrollment
- 43
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.